We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Gynaecological
Digital Poster
Clinical
Potential reduction in normal tissue toxicity with robustly optimized IMPT for vulvar cancer: a dosimetric and NTCP comparison with VMAT
Mischa Hoogeman, The Netherlands
-37
Management of Radiation-Induced Gynecological Toxicities: AFSOS-SFCE-GFRCP Clinical Practice Guidelines
Jean-Christophe FAIVRE, France
-234
Clinical challenges in the adaptation of AI predictive models in radiation oncology for gynecological cancer: a systematic review by the AI MITO Group
Donato Pezzulla, Italy
-695
Stratifying oligometastatic recurrence probability and prognostic profile in locally advanced cervical cancer through FDG-PET response assessment.
Federica Medici, Italy
-739
A prospective audit of treatment interruptions in cervical cancer radiotherapy and impact of a mobile-based patient tracking system in Bangladesh
Mahbuba Tania, Bangladesh
-939
Factors driving longer survival after brain metastases in ovarian cancer: importance of ECOG, extra-cranial disease control and platinum sensitivity.
Enar Recalde, Spain
-955
Neoadjuvant chemotherapy followed by radical chemoradiotherapy improves outcomes in locally advanced cervical cancer: Mature realworld data from LMIC.
sushma agrawal, India
-1070
Impact of Molecular classification on Adjuvant Treatment in Surgically staged Endometrial cancer patients in a High Volume Tertiary Centre in LMIC
Madhuri Kavikondala, India
-1224
Impact of primary radiotherapy on the psychosocial well-being of patients with locally advanced cervical cancer (IMPRaCC study).
Henrike Westerveld, The Netherlands
-1288
Real-World Outcomes of Induction Chemotherapy in Locally Advanced Cervical Cancer
Gemma Eminowicz, United Kingdom
-1431
Sarcopenic obesity in locally advanced cervical cancer: the hidden prognostic impact of body composition
Raouia Ben Amor, Tunisia
-1442
A multi-institutional case series on moderate hypofractionated radiotherapy for symptom relief in locally advanced and metastatic gynecologic cancers
Vannesza Hendricke Chua, Philippines
-1497
Recurrence pattern of Definitive Radiotherapy in Elderly Patients with Locally Advanced Uterine Cervical Cancer
Takeshi Fujisawa, Japan
-1502
Daily CBCT-based online adaptive external-beam radiotherapy with weekly MRI-guidance in cervical cancer: dosimetric impact and toxicity outcomes
Jan-Hendrik Bolten , Germany
-1929
Predictive Value of Pre-Treatment CBC-based Inflammatory Biomarkers on Acute Hematologic Toxicity in Locally Advanced Cervical Cancer Chemoradiation
Rosa Lea Baldevarona, Philippines
-1971
Therapeutic results and impact of dose escalation and interstitial image-guided brachytherapy in locally advanced cervical cancer in a Tunisian cohort
Omar Nouri, Tunisia
-2111
Postoperative proton beam therapy for uterine cervical or endometrial cancer (APROVE II) – a prospective, multicenter, randomized trial
Lars Wessel, Germany
-2122
QUALITY OF LIFE AND SEXUAL HEALTH  cervical cancer: early stages and locally advanced
Sofia Cordoba Largo, Spain
-2350
Failure Pattern and Survival Impact of Modern Radiotherapy for Locally Advanced Cervical Cancer: Real-World vs EMBRACE II in Single Institute
Tissana Prasartseree, Thailand
-2405
Real-world surveillance patterns in gynaecological cancers: Insights from the Y-ECI EORTC survey.
Noelia Sanmamed Salgado, Spain
-2428
Association between bone marrow dose–SUV distribution and hematologic toxicity in pelvic chemoradiotherapy for cervical cancer
Fumiaki ISOHASHI, Japan
-2549
Longitudinal health-related quality of life trends in rare and radioresistant gynaecological cancer patients undergoing hadrontherapy
Alessandro Vai, Italy
-2782
Benchmarking analysis of radiotherapy timeliness and impact on progression free survival in stage IIIC cervical cancer patients
Marija Živković Radojević, Serbia
-2797
Real world data on Neoadjuvant chemotherapy in carcinoma uterine cervix: time to tie the LACES or EMBRACE the standard?
Sagarika Nithyanand, India
-2885
Towards refining normal tissue dose objectives beyond the EMBRACE II protocol in cervical cancer external beam radiotherapy
Simona Šimůnková, Czech Republic
-2963
Prevalence of geriatric syndromes and their association with quality of life in older women with cervical cancer
Alma Nelly Jaramillo, Mexico
-2992
Is Underweight a Risk Factor for Poor Prognosis in Cervical Cancer?
Dunhuang Wang, China
-3115
The Impact of Uterine Cancer on Conjugal Life : A study of a Tunisian Cohort
Samia Zaraa, Tunisia
-3342
Using Patient Reported Outcomes (PRO) for organ dose guidance: weekly gastrointestinal symptom evolution during radiotherapy for cervix cancer.
Enar Recalde, Spain
-3414
How Does Uterine Cancer Treatment Impact sexual function?
Samia Zaraa, Tunisia
-3502
Radiation-induced toxicities in obese patients with endometrial cancer: beyond BMI?
Nabila SELLAL, Morocco
-3504
Impact of treatment interruptions on tumor regression in cervical cancer patients treated with MR-guided radiotherapy on the 1.5T Unity MR-Linac
Perla Zidane, France
-3868
Impact Of Nutrition on Clinical Outcomes in Endometrial Cancer Patients treated with Adjuvant Radiotherapy
Beatriz Gil Haro, Spain
-3990
Low-Dose, High-Sparing: Fertility Preservation through Particle Therapy in AYA Patients
Yvonne Goy, Austria
-4110
“Hidden Battles: Sexual Dysfunction and Quality of Life Challenges in Cervical Cancer Survivorship”
ALTAF HOSSAIN, Bangladesh
-4342
Cervical cancer outcomes may be predicted by NGAL, a cancer-related glycoprotein that correlates with FIGO stage, operability,HPV subtype alterations.
Behar Raci, Kosovo
-4348
Adjuvant Small-Field Pelvic Radiotherapy after Radical Hysterectomy in Intermediate-Risk Early-Stage Cervical Cancer: Long-Term Overall Survival
Tomás Walter, Chile
-4761
Impact of nodal characteristic and treatment technique on failure patterns in cervical cancer IGABT-based chemoradiotherapy: A competing risk analysis
Wiwatchai Sittiwong, Thailand
-4845
Treatment and outcomes of primary vaginal cancer. A single institution experience.
Camelia Frimodig, Sweden
-4906
Improved target coverage for cervical cancer regional hyperthermia using HyperPlan® for the clinical BSD2000 system: a simulation study
Siddharth Arora , Germany
-5049
Summative dose feasibility of “Brachy-like” SBRT with MRgRT + VMAT 40Gy/20F + Image guided adaptive brachytherapy for cervical cancer: UPFRONTCx study
Tissana Prasartseree, Thailand
-5085
Impact of Stereotactic Radiotherapy on Disease Control and Survival After Oligoprogression during PARPi in ovarian cancer:A Correlative Analysis
BIANCA SANTO, Italy
-5146
Mapping Locoregional Failures After Adjuvant Radiotherapy in Endometrial Cancer: Prognostic factors and Radiotherapy Field-Based Patterns
Aditya Agrawal, United Kingdom
-5165
Clinical implementation and early outcomes of adaptive radiotherapy with Ethos™ for cervical cancer
Irene Garcia, Spain
-4404